BioSight
Companies
Merck & Co., Inc. logo

MRK

NYSERAHWAY, NJ
Merck & Co., Inc.

Merck & Co., Inc. is a global pharmaceutical and animal health company that discovers, develops, and manufactures prescription medicines, biologic therapies, and vaccines for human diseases as well as veterinary products for livestock and companion animals. Merck's human pharmaceutical portfolio includes both therapeutic treatments and preventive vaccines across multiple disease areas, with its leading product being Keytruda (an immunotherapy), along with vaccines like Gardasil and treatments for diabetes and other conditions. The company operates two segments—Pharmaceutical (human health medicines and vaccines) and Animal Health (veterinary pharmaceuticals, vaccines, and health management solutions)—and sells primarily to wholesalers, retailers, hospitals, physicians, and government agencies.

$109.18+32.80%1Y
MRK · daily close · illustrative · 0 catalysts marked
$66$81$97$113$128Apr '25Aug '25Dec '25Apr '26
1Y high$123.181Y low$70.89range$52.29(74%)past catalysts

Pipeline7

Phase 2Small Cell Lung Cancer
Phase 2Neuroendocrine Carcinoma
small-molecule
Phase 2Renal Cell Carcinoma (RCC)
Phase 2Clear Cell Renal Cell Carcinoma (ccRCC)
Phase 2Kidney Cancer
Phase 2Renal Cancer
Phase 2Renal Cell Cancer Metastatic
Phase 2Renal Cell Cancer, Recurrent
Phase 2Kidney
Phase 2VHL - Von Hippel-Lindau Syndrome
Phase 2VHL Gene Mutation
Phase 2VHL Syndrome
Phase 2VHL Gene Inactivation
Phase 2VHL-Associated Renal Cell Carcinoma
Phase 2VHL-Associated Clear Cell Renal Cell Carcinoma
small-molecule
Phase 2Renal Cell Carcinoma (RCC)
Phase 2Clear Cell Renal Cell Carcinoma (ccRCC)
Phase 2Kidney Cancer
Phase 2Renal Cancer
Phase 2Renal Cell Cancer Metastatic
Phase 2Renal Cell Cancer, Recurrent
Phase 2Kidney
small-molecule
Phase 2Small Cell Lung Cancer
Phase 2Neuroendocrine Carcinoma
small-molecule
Phase 2Small Cell Lung Cancer
Phase 2Neuroendocrine Carcinoma
small-molecule
Phase 2Lymphoma, B-Cell
Phase 2Small Lymphocytic Lymphoma
Phase 2Chronic Lymphocytic Leukemia
Phase 2Waldenstrom Macroglobulinemia
Phase 2Mantle-cell Lymphoma
Phase 2Diffuse Large B-Cell Lymphoma
Phase 2Richter's Transformation
Phase 2Follicular Lymphoma
Phase 2Marginal Zone Lymphoma
small-molecule
Phase 2Diffuse Cutaneous Systemic Sclerosis
Phase 2Interstitial Lung Disease
small-molecule

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar